|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,050 KRW | -2.89% |
|
-2.42% | +13.72% |
OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:A131030) announces a share repurchase program. Under the program, the company will repurchase up to 463,678 shares. The purpose of the program is stock price stability and shareholder value enhancement.
The program will end on November 7, 2022. As of September 6, 2022, the company had 523,536 shares in treasury within the scope available for dividend and no shares in treasury through other repurchase.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.72% | 71.16M | |
| +4.16% | 69.91B | |
| +11.37% | 9.03B | |
| -17.03% | 4.75B | |
| +37.51% | 4.31B | |
| +3.92% | 3.88B | |
| +18.14% | 2.37B | |
| -24.13% | 2.26B | |
| -29.70% | 2.2B | |
| +9.09% | 1.98B |
OPTUS PHARMACEUTICAL CO., LTD. 
